Induced Pluripotent Stem Cells Derived Extracellular Vesicles: A Potential Therapy for Cardiac Repair

Affiliations

¹ From the Center for Translational Medicine (V.N.S.G., R.K.) and Department of Pharmacology (R.K.), Temple University School of Medicine, Philadelphia, PA.
² From the Center for Translational Medicine (V.N.S.G., R.K.) and Department of Pharmacology (R.K.), Temple University School of Medicine, Philadelphia, PA. raj.kishore@temple.edu.

Editorial

Venkata Naga Srikanth Garikipati et al. Circ Res. 2018.

. 2018 Jan 19;122(2):197-198.

doi: 10.1161/CIRCRESAHA.117.312394.

¹ From the Center for Translational Medicine (V.N.S.G., R.K.) and Department of Pharmacology (R.K.), Temple University School of Medicine, Philadelphia, PA.
² From the Center for Translational Medicine (V.N.S.G., R.K.) and Department of Pharmacology (R.K.), Temple University School of Medicine, Philadelphia, PA. raj.kishore@temple.edu.

No abstract available

Keywords: Editorials; cell differentiation; extracellular vesicles; humans; myocardium.

Comment on

Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.
Adamiak M, Cheng G, Bobis-Wozowicz S, Zhao L, Kedracka-Krok S, Samanta A, Karnas E, Xuan YT, Skupien-Rabian B, Chen X, Jankowska U, Girgis M, Sekula M, Davani A, Lasota S, Vincent RJ, Sarna M, Newell KL, Wang OL, Dudley N, Madeja Z, Dawn B, Zuba-Surma EK. Adamiak M, et al. Circ Res. 2018 Jan 19;122(2):296-309. doi: 10.1161/CIRCRESAHA.117.311769. Epub 2017 Nov 8. Circ Res. 2018. PMID: 29118058 Free PMC article.

1. Sanganalmath SK, Bolli R. Cell therapy for heart failure: A comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113:810–834. - PMC - PubMed
1. Chong JJ, Yang X, Don CW, Minami E, Liu YW, Weyers JJ, Mahoney WM, Van Biber B, Cook SM, Palpant NJ, Gantz JA, Fugate JA, Muskheli V, Gough GM, Vogel KW, Astley CA, Hotchkiss CE, Baldessari A, Pabon L, Reinecke H, Gill EA, Nelson V, Kiem HP, Laflamme MA, Murry CE. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. 2014;510:273–277. - PMC - PubMed
1. Hartman ME, Dai DF, Laflamme MA. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev. 2016;96:3–17. - PMC - PubMed
1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. - PubMed
1. Yoshida Y, Yamanaka S. Induced pluripotent stem cells 10 years later: For cardiac applications. Circ Res. 120:1958–1968. - PubMed